Products include spacers, foams and powders. They are available in either plant-based or chitosan polysaccharide polymers.
Olympus has entered into a distribution partnership with Hemostasis for the products.
“The new offerings extend Olympus’ current world-class ENT solutions to surgeons performing sinus and anterior skull base procedures and their patients,” said Perry Mykleby, vice president of marketing for Olympus’ ENT sales, in the release. “We are pleased to collaborate with Hemostasis, a high-quality medical device manufacturer partner, to enhance patient care.”
More Articles Featuring Olympus:
Olympus Introduces New Suite of Single-Use Aspiration Needles
Olympus Launches New Peracetic Acid Solution for High-Level Disinfection
Olympus America, Caris Diagnostics Partner on New Pathology Reporting Tool
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
